OnCo
technologiesTechnologyEstablished

Cardio-oncology

Protecting the heart from cancer treatments, which is increasingly important as patients live longer.

Anthracycline and trastuzumab cardiotoxicity, checkpoint-inhibitor myocarditis, TKI hypertension and QT prolongation, and radiation heart disease. Baseline and serial echocardiography with strain imaging, troponin/BNP monitoring, and cardioprotective drugs (dexrazoxane, ACE inhibitors, statins).

Schematic · not to scale
Heart under treatment · Echo / troponin surveillance

How it works

Risk stratification, surveillance, and prevention integrated into oncology care.

Strengths
  • Enables completion of curative therapy
Limitations
  • Workforce and access

Products

1top

Key papers

1top

Latest papers

top
Literature trend1,538 papers in the last 12 months+20% vs prior 12How this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"cardio-oncology" OR ABSTRACT:"cardio-oncology" OR TITLE:"cardiotoxicity" OR ABSTRACT:"cardiotoxicity") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Cardio-oncology, not a curated reading list.

Connected

35top

Pages like this

not linked directly; found by shared links

cancers

7

fronts

1

technologies

4

drugs

1

institutions

1

terms

5

pairings

2

roadmaps

1

ideas

6

people

2

bottlenecks

4

key papers

1